MedTrace Logo

Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension

NCT02885155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-08-31

No results posted yet for this study

Summary

The purpose of this study is to determine the prognostic value of echocardiographic parameters in comparison with clinical and hemodynamic parameters in pulmonary arterial hypertension (PAH).

A secondary purpose of this study is to analyze the disease evolution after 3 to 6 months. In pulmonary fibrosis it has been demonstrated that the variation of clinical and paraclinical parameters between 2 examinations has a prognostic interest. In this study the prognostic value of variation of some echocardiographic parameters between initial examination and echocardiography after 3 or 6 months will be evaluated.

Another secondary purpose is to create a common database for Pneumology, Cardiology and Epidemiology departments with prospective registration of new cases of PAH and follow of patients under treatment.

Conditions

Interventions

OTHER

Echocardiography

planned at regular intervals

OTHER

Hemodynamic examinations (right cardiac catheterization)

planned at regular intervals

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • François Chabot, Pr · Service de Maladies Respiratoires et Réanimation Respiratoire - CHU Nancy

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02885155 on ClinicalTrials.gov